8-K

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

February 6, 2013

Period of Report

January 31, 2013

Accession Number

0001144204-13-006403

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →